GS

Gillian Sandler

North America, New York, United States

Description

Gillian Sandler

Investor Profile

Gillian Sandler has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gillian Sandler frequently co-invest with?

DB
North America, New York, United States, New York
Co-Investments: 1
Bow Capital
North America, California, United States, Menlo Park
Co-Investments: 1
GreatPoint Ventures
North America, Michigan, United States, New Haven
Co-Investments: 1
Divergent Investments
North America, California, United States, San Carlos
Co-Investments: 1

Which angels does Gillian Sandler often collaborate with?

NS
North America, California, United States, San Francisco
Shared Deals: 1
SR
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Gillian Sandler?

Linus Biotechnology

New Rochelle, New York, United States

Linus Biotechnology develops a technology platform to improve human health through precision exposome medicine.

BiotechnologyHealth CarePharmaceutical
Series AJan 5, 2023
Amount Raised: $16,000,000